Allele frequencies of human platelet antigens in Banjar, Bugis, Champa, Jawa and Kelantan Malays in Peninsular Malaysia. Issue 5 (1st July 2015)

• Record Type: Journal Article
• Authors: Wan Syafawati, W. U.; Norhalifah, H. K.; Zefarina, Z.; Zafarina, Z.; Panneerchelvam, S.; Norazmi, M. N.; Chambers, G. K.; Edinur, H. A.
• Is Part Of: Transfusion medicine. Volume 25:Issue 5(2015)
• Page Start: 326
• Page End: 332
• Publication Date: 2015-07-01
• Subjects: human platelet antigen -- Malay sub‐ethnic groups -- PCR‐SSP -- Peninsular Malaysia; Blood -- Transfusion -- Periodicals; 615.39
• DOI: 10.1111/tme.12220
• Languages: English
• ISSNs: 0958-7578

Abstract

SUMMARY: Objectives: The major aims of this study are to characterise and compile allelic data of human platelet antigen (HPA)‐1 to ‐6 and ‐15 systems in five Malay sub‐ethnic groups in Peninsular Malaysia. Background: HPAs are polymorphic glycoproteins expressed on the surface of platelet membranes and are genetically differentiated across ethnogeographically unrelated populations. Methods: Blood samples were obtained with informed consent from 192 volunteers: Banjar ( n = 30), Bugis ( n = 37), Champa ( n = 51), Jawa ( n = 39) and Kelantan ( n = 35). Genotyping was done using polymerase chain reaction‐sequence specific primer method. Results: In general, frequencies of HPAs in the Malay sub‐ethnic groups are more similar to those in Asian populations compared with other more distinct populations such as Indians, Australian Aborigines and Europeans. Conclusions: This study provides the first HPA datasets for the selected Malay sub‐ethnic groups. Subsequent analyses including previously reported HPA data of Malays, Chinese and Indians revealed details of the genetic relationships and ancestry of various sub‐populations in Peninsular Malaysia. Furthermore, the comprehensive HPA allele frequency information from Peninsular Malaysia provided in this report has potential applications for future study of diseases, estimating risks associated with HPA alloimmunization and for developing an efficient HPA‐typed donor recruitment strategy.